跳至主要内容
临床试验/NCT03997253
NCT03997253招募中不适用

Optimizing Long-term Survival in Organ Transplantation: From Physiopathology to Optimized Patient Management

University Hospital, Limoges7 个研究点 分布在 1 个国家目标入组 430 人开始时间: 2020年12月21日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
430
试验地点
7
主要终点
Survival of the graft

研究概览

简要总结

Increased indications for transplantation continue to worsen the shortage of organs and need the extension of graft sampling criteria and the search for new potential sources of organs. Despite undeniable success in the short term, due to major advances in surgery, medicine and research, transplant recipients continue to face the risk of chronic rejection and long-term complications.

The University Hospital Federation "FHU SUPORT" was created to optimize the chances of success of the organ transplant and improve the quality of life of the transplanted patient. FHU SUPORT 's ambition is based on a translational strategy that presents two priority areas:

Axis 1: Optimization, evaluation, conditioning of the donor, graft, recipient Axis 2: Personalized follow-up of the transplanted patient in the short and long term Identifying factors for long-term graft and patient survival through translational research from a common cohort and biological collection will predict transplant rejection, prolong graft function, or improve the patient's care.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female over 18 (no age limit)
  • affiliated to a social security organization
  • Recipient (s) of a kidney, liver or heart transplant
  • followed by at least one of the FHU SUPORT centers (Tours, Poitiers, Limoges, Rennes)
  • having given informed consent to participate in the cohort.

排除标准

  • Patient unable to understand the information given by the investigator
  • People under the protection of justice

研究组 & 干预措施

blood, bile and urine samples

Experimental

blood and urine samples at D0,D1, D3 D7, D14, M1, M3, M6 and M12

干预措施: blood and urine samples (Other)

结局指标

主要结局

Survival of the graft

时间窗: 12 months

次要结局

未报告次要终点

研究者

发起方
University Hospital, Limoges
申办方类型
Other
责任方
Sponsor

研究点 (7)

Loading locations...

相似试验

Optimizing Long-term Survival in Organ... | 临床试验